1/05/2022

Anti-viral therapy for Covid (as of 1/5/22)

 1) Sotrovimab IV - Monoclonal antibodies - reduces hospitalization by 90%, effective against Omicron variant.

2) Oral Paxlovid (Nirmatlevir/Ritonavir)  - x 5 days - reduces hospitalization by 90%.

3) Remdesvir IV - x 3 days - reduces hospitalization by 90%.

4) Oral Molnupiravir - x 5 days - reduces hospitalization by 30%.